袖状胃切除术患者胃食管反流病诊治专家共识（2024版）

doi:10.3877/cma.j.issn.2095-9605.2024.03.001

病态肥胖及其伴随疾病已是全世界需要共同面对的严重公众卫生问题之一，而减重代谢手术到目前为止是长期控制体重最有效的方法。在所有的减重术式中，袖状胃切除术（SG）是目前应用最广泛的一种术式，但它并不是完美的术式。术后可能加重原有的或出现新发的胃食管反流病（GERD）一直是SG所要面对的最严重的问题之一。然而目前关于SG患者GERD的诊治方面还缺乏高级别临床实验的证据。因此，由国内四家减重中心发起，并联合来自中日韩三国的41位在减重代谢手术及GERD诊治上有丰富经验的专家，以Delphi法来达成SG患者GERD诊治的共识。该共识59个征询问题，其中44个达成共识，旨在为临床诊断与治疗提供参考，为未来高质量临床研究指明方向。

关键词: 肥胖症, 减重代谢手术, 袖状胃切除术, 胃食管反流病, 食管裂孔疝, 并发症

Mobid obesity and its accompanying diseases have become one of the most serious public health problems that the whole world needs to face together, and bariatric and metabolic surgery is still the most effective method for long-term weight control. Among all bariatric and metabolic procedures, sleeve gastrectomy (SG) is currently the most widely used, but it is not a perfect procedure. One of the most serious issues that this surgical procedure faces is the possibility of worsening existing or developing de novo gastroesophageal reflux disease (GERD) after surgery. Moreover, there is currently a lack of high-level clinical trial evidence on the diagnosis and treatment of GERD in patients undergoing SG. Therefore, initiated by four domestic bariatric and metabolic surgery centers, 41 experts with rich experience in metabolic and bariatric surgery and diagnosis and treatment of GERD from China, Japan, and South Korea reached a consensus on the diagnosis and treatment of gastroesophageal reflux disease in sleeve gastrectomy patients using the Delphi method. There are a total of 59 consultation questions in this consensus, of which 44 have reached a consensus. We hope that this consensus can not only serve as a reference for clinical diagnosis and treatment, but also provide more possible directions for future high-quality clinical research.

Key words: Obesity, Metabolic and bariatric surgery, Sleeve gastrectomy (SG), Gastroesophageal reflux disease (GERD), Hiatal hernia, Complication

表1 SG患者术前GERD的评估及术式选择

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
1.病态肥胖合并GERD患者需要手术治疗时，建议行减重手术	41	0	0	100.00%	是
2.除了少部分严重的GERD患者，大多数病态肥胖伴GERD患者可以选择SG	33	6	2	80.49%	是
3.对于LA-C或LA-D的严重GERD或者BE患者，应避免行SG/OAGB	31	4	6	75.61%	是
4.对于LA-C或LA-D的严重GERD或者巴雷特食管患者，应建议行RYGB	38	0	3	92.68%	是
5.对于术前存在烧心、反流或胸痛、上腹痛、上腹胀、嗳气等不典型症状的病态肥胖患者，应常规进行反流性疾病问卷量表和GERD问卷量表的评估	37	1	3	90.24%	是
6.建议所有拟接受减重代谢手术的患者术前常规进行上消化道内镜检查	39	2	0	95.12%	是
7.术前对是否合并HH及其分型进行详尽的评估，为术式选择提供参考	40	0	1	97.56%	是
8.对于术前高度怀疑GERD又缺乏诊断依据的患者应转至有条件的医院行食管反流监测及高分辨率食管测压明确诊断	28	8	5	68.29%	否

表1 SG患者术前GERD的评估及术式选择

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
1.病态肥胖合并GERD患者需要手术治疗时，建议行减重手术	41	0	0	100.00%	是
2.除了少部分严重的GERD患者，大多数病态肥胖伴GERD患者可以选择SG	33	6	2	80.49%	是
3.对于LA-C或LA-D的严重GERD或者BE患者，应避免行SG/OAGB	31	4	6	75.61%	是
4.对于LA-C或LA-D的严重GERD或者巴雷特食管患者，应建议行RYGB	38	0	3	92.68%	是
5.对于术前存在烧心、反流或胸痛、上腹痛、上腹胀、嗳气等不典型症状的病态肥胖患者，应常规进行反流性疾病问卷量表和GERD问卷量表的评估	37	1	3	90.24%	是
6.建议所有拟接受减重代谢手术的患者术前常规进行上消化道内镜检查	39	2	0	95.12%	是
7.术前对是否合并HH及其分型进行详尽的评估，为术式选择提供参考	40	0	1	97.56%	是
8.对于术前高度怀疑GERD又缺乏诊断依据的患者应转至有条件的医院行食管反流监测及高分辨率食管测压明确诊断	28	8	5	68.29%	否

表2 SG术中减少GERD发生的技术要点

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
9.重视SG的手术操作细节，在一定程度上可以避免加重术后的GERD	36	1	4	87.80%	是
10.手术时应通过合理保留胃窦，距离幽门4~6 cm以上开始切割可以有效降低术后GERD的发生率	29	6	6	70.73%	是
11.合理选择支撑管的大小可以在保证手术效果的同时减少术后GERD的发生，推荐使用36~38 Fr的支撑管。	35	6	0	85.37%	是
12.完整切除胃底，同时注意距离His角1.0~1.5 cm进行切割，有助于缓解SG后GERD的发生	34	1	6	82.93%	是
13.尽量保持残胃上窄下宽的形态；避免对左侧膈肌脚的过度分离和破坏，有助于缓解SG术后GERD的发生	35	2	4	85.37%	是
14.手术时不应该切除胃食管结合部的脂肪垫，可以减少SG术后胃上移进入纵膈的机会	28	7	6	68.29%	否
15.选择适当的缝合材料和技术对于减少SG术后的GERD有重要意义	26	10	5	63.41%	否
16.在行SG时，如术中发现存在HH，应同时行修补以减少术后GERD的发生	34	3	4	82.93%	是
17.当食管食管前上方韧带凹陷，横径≥2 cm或食管周围有组织疝出进入胸腔时，应考虑存在HH？	37	2	2	90.24%	是
18.如术中考虑有HH，应该选择的修补的方式是：完全游离，按照标准的HH直接缝合方式进行修补	32	3	6	78.05%	是
19.加做抗反流术式的各种新型减重术式有较好的缓解GERD的近期疗效。但其安全性和远期效果还有待更长时间和更多病例的随访	36	1	4	87.80%	是

表2 SG术中减少GERD发生的技术要点

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
9.重视SG的手术操作细节，在一定程度上可以避免加重术后的GERD	36	1	4	87.80%	是
10.手术时应通过合理保留胃窦，距离幽门4~6 cm以上开始切割可以有效降低术后GERD的发生率	29	6	6	70.73%	是
11.合理选择支撑管的大小可以在保证手术效果的同时减少术后GERD的发生，推荐使用36~38 Fr的支撑管。	35	6	0	85.37%	是
12.完整切除胃底，同时注意距离His角1.0~1.5 cm进行切割，有助于缓解SG后GERD的发生	34	1	6	82.93%	是
13.尽量保持残胃上窄下宽的形态；避免对左侧膈肌脚的过度分离和破坏，有助于缓解SG术后GERD的发生	35	2	4	85.37%	是
14.手术时不应该切除胃食管结合部的脂肪垫，可以减少SG术后胃上移进入纵膈的机会	28	7	6	68.29%	否
15.选择适当的缝合材料和技术对于减少SG术后的GERD有重要意义	26	10	5	63.41%	否
16.在行SG时，如术中发现存在HH，应同时行修补以减少术后GERD的发生	34	3	4	82.93%	是
17.当食管食管前上方韧带凹陷，横径≥2 cm或食管周围有组织疝出进入胸腔时，应考虑存在HH？	37	2	2	90.24%	是
18.如术中考虑有HH，应该选择的修补的方式是：完全游离，按照标准的HH直接缝合方式进行修补	32	3	6	78.05%	是
19.加做抗反流术式的各种新型减重术式有较好的缓解GERD的近期疗效。但其安全性和远期效果还有待更长时间和更多病例的随访	36	1	4	87.80%	是

表3 SG术后GERD的评估及非手术治疗

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
20. SG术后会出现GERD的加重或出现新发的GERD	35	2	4	85.37%	是
21. SG术后，BE的发生率升高	19	7	15	46.34%	否
22. SG术后，高发的GERD并不会引起食管腺癌发生率的增加	18	8	15	43.90%	否
23. SG术后是否存在GERD，也需要与术前相同的方法进行准确评估	38	2	1	92.68%	是
24. SG术后的患者，均需要进行GERD相关病史的采集及主观症状的评分	41	0	0	100.00%	是
25.术后出现GERD的患者，根据患者症状的严重程度决定胃镜随访时间，建议在SG术后3~6个月	31	6	4	75.61%	是
26.术后无GERD的患者，也需要行胃镜检查评估，建议在SG术后12月	40	0	1	97.56%	是
27.术后GERD长时间不缓解或症状不典型的，需要食管高分辨率压力检测及食管24 h pH监测	33	4	4	80.49%	是
28.术后GERD长时间不缓解，需要行进一步检查除外HH	37	3	1	90.24%	是
29.生活方式改变是帮助缓解术后GERD的重要手段	39	2	0	95.12%	是
30.术后需要预防性用药缓解GERD	35	3	3	85.37%	是
31.术后预防性抑酸治疗一般在术后3~7 d开始	35	5	1	85.37%	是
32.术后预防性抑酸治疗一般持续3~6个月	27	8	6	65.85%	否
33.改变生活习惯后，GERD症状仍不缓解，应按需给予药物治疗	40	1	0	97.56%	是
34.药物治疗首选PPI，治疗方案和其他病因引起的GERD相同	40	1	0	97.56%	是
35.术后GERD的患者，药物治疗效果不佳的，要充分考虑心理社会因素的影响并给予适当的干预	39	1	1	95.12%	是
36.术后GERD的患者，药物治疗效果不佳或不能停药的，要进行进一步评估	40	1	0	97.56%	是
37.对于诊断明确又没有明显解剖异常的GERD，药物治疗效果不佳或者不能停药的，可以考虑内镜下抗反流黏膜干预措施	32	2	7	78.05%	是
38.抗反流黏膜干预措施早期疗效较好，但其长期的治疗效果还有待更长时间的随访和更多病例的积累	39	0	2	95.12%	是
39.残胃狭窄引起的GERD，可考虑行内镜下扩张术	39	2	0	95.12%	是

表3 SG术后GERD的评估及非手术治疗

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
20. SG术后会出现GERD的加重或出现新发的GERD	35	2	4	85.37%	是
21. SG术后，BE的发生率升高	19	7	15	46.34%	否
22. SG术后，高发的GERD并不会引起食管腺癌发生率的增加	18	8	15	43.90%	否
23. SG术后是否存在GERD，也需要与术前相同的方法进行准确评估	38	2	1	92.68%	是
24. SG术后的患者，均需要进行GERD相关病史的采集及主观症状的评分	41	0	0	100.00%	是
25.术后出现GERD的患者，根据患者症状的严重程度决定胃镜随访时间，建议在SG术后3~6个月	31	6	4	75.61%	是
26.术后无GERD的患者，也需要行胃镜检查评估，建议在SG术后12月	40	0	1	97.56%	是
27.术后GERD长时间不缓解或症状不典型的，需要食管高分辨率压力检测及食管24 h pH监测	33	4	4	80.49%	是
28.术后GERD长时间不缓解，需要行进一步检查除外HH	37	3	1	90.24%	是
29.生活方式改变是帮助缓解术后GERD的重要手段	39	2	0	95.12%	是
30.术后需要预防性用药缓解GERD	35	3	3	85.37%	是
31.术后预防性抑酸治疗一般在术后3~7 d开始	35	5	1	85.37%	是
32.术后预防性抑酸治疗一般持续3~6个月	27	8	6	65.85%	否
33.改变生活习惯后，GERD症状仍不缓解，应按需给予药物治疗	40	1	0	97.56%	是
34.药物治疗首选PPI，治疗方案和其他病因引起的GERD相同	40	1	0	97.56%	是
35.术后GERD的患者，药物治疗效果不佳的，要充分考虑心理社会因素的影响并给予适当的干预	39	1	1	95.12%	是
36.术后GERD的患者，药物治疗效果不佳或不能停药的，要进行进一步评估	40	1	0	97.56%	是
37.对于诊断明确又没有明显解剖异常的GERD，药物治疗效果不佳或者不能停药的，可以考虑内镜下抗反流黏膜干预措施	32	2	7	78.05%	是
38.抗反流黏膜干预措施早期疗效较好，但其长期的治疗效果还有待更长时间的随访和更多病例的积累	39	0	2	95.12%	是
39.残胃狭窄引起的GERD，可考虑行内镜下扩张术	39	2	0	95.12%	是

表4 SG术后GERD的修正手术

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
40.修正手术的目的是改善患者GERD症状，提高患者生活质量，并防止GERD及GERD并发症的进一步进展	41	0	0	100.00%	是
41.修正手术前应该至少有6~12个月的正规GERD治疗证据（包括强化生活方式干预和药物治疗）	38	2	1	92.68%	是
42.无论进行何种修正手术，术前都需要以同样的方法进行准确评估GERD，减重效果以及全身情况	41	0	0	100.00%	是
43.对于减重效果理想，GERD诊断明确又没有明确HH的患者，可考虑行RYGB	34	7	0	82.93%	是
44.减重效果理想，GERD诊断明确又有明确HH的患者，药可考虑行HH修补+RYGB	33	6	2	80.49%	是
45.对于减重效果理想，GERD诊断明确又没有明确HH的患者，可考虑行磁环抗反流装置治疗	26	6	9	63.41%	否
46.减重效果理想，GERD诊断明确又有明确HH的患者，可考虑行HH修补术+磁环抗反流装置。	20	12	9	48.78%	否
47.减重效果理想，GERD诊断明确又有明确HH的患者，可考虑行单纯HH修补术	32	8	1	78.05%	是
48.减重效果理想，GERD诊断明确又有明确HH的患者，可考虑行HH修补术+胃固定术	28	11	2	68.29%	否
49.减重效果不理想/复胖，GERD诊断明确又无明确HH的患者，胃扩张、胃形态正常，可考虑行Re-SG	21	17	3	51.22%	否
50.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，胃扩张、胃形态正常，可考虑行管裂孔疝修补+Re-SG	20	19	2	48.78%	否
51.减重效果不理想/复胖，GERD诊断明确又无明确HH的患者，胃扩张、胃形态正常，可考虑行Re-SG+胃底折叠术	19	18	4	46.34%	否
52.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，胃扩张、胃形态正常，可考虑行管裂孔疝修补+Re-SG+胃底折叠术	18	18	5	43.90%	否
53.减重效果不理想/复胖，GERD诊断明确又无明确HH的患者，胃扩张、胃形态正常，可考虑行Re-SG+His角重建	24	15	2	54.54%	否
54.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，胃扩张、胃形态正常，可考虑行管裂孔疝修补+Re-SG+His角重建	21	18	2	51.22%	否
55.减重效果不理想/复胖，GERD诊断明确又没有明确HH的患者，无胃扩张/胃扭转，可考虑行RYGB	35	5	1	85.37%	是
56.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，无胃扩张/胃扭转，可考虑行HH修补+RYGB	39	1	1	95.12%	是
57.减重效果理想，残胃狭窄引起的GERD，反复内镜下扩张失败的，可考虑行RYGB	37	3	1	90.24%	是
58.减重效果不理想/复胖，残胃狭窄引起的GERD，可考虑行RYGB	39	2	0	95.12%	是
59.若修正手术前合并难以纠正的贫血/营养不良，应慎重考虑RYGB	38	3	0	92.68%	是

表4 SG术后GERD的修正手术

征询问题	同意（票）	不同意（票）	不确定（票）	比例（%）	是否达成共识
40.修正手术的目的是改善患者GERD症状，提高患者生活质量，并防止GERD及GERD并发症的进一步进展	41	0	0	100.00%	是
41.修正手术前应该至少有6~12个月的正规GERD治疗证据（包括强化生活方式干预和药物治疗）	38	2	1	92.68%	是
42.无论进行何种修正手术，术前都需要以同样的方法进行准确评估GERD，减重效果以及全身情况	41	0	0	100.00%	是
43.对于减重效果理想，GERD诊断明确又没有明确HH的患者，可考虑行RYGB	34	7	0	82.93%	是
44.减重效果理想，GERD诊断明确又有明确HH的患者，药可考虑行HH修补+RYGB	33	6	2	80.49%	是
45.对于减重效果理想，GERD诊断明确又没有明确HH的患者，可考虑行磁环抗反流装置治疗	26	6	9	63.41%	否
46.减重效果理想，GERD诊断明确又有明确HH的患者，可考虑行HH修补术+磁环抗反流装置。	20	12	9	48.78%	否
47.减重效果理想，GERD诊断明确又有明确HH的患者，可考虑行单纯HH修补术	32	8	1	78.05%	是
48.减重效果理想，GERD诊断明确又有明确HH的患者，可考虑行HH修补术+胃固定术	28	11	2	68.29%	否
49.减重效果不理想/复胖，GERD诊断明确又无明确HH的患者，胃扩张、胃形态正常，可考虑行Re-SG	21	17	3	51.22%	否
50.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，胃扩张、胃形态正常，可考虑行管裂孔疝修补+Re-SG	20	19	2	48.78%	否
51.减重效果不理想/复胖，GERD诊断明确又无明确HH的患者，胃扩张、胃形态正常，可考虑行Re-SG+胃底折叠术	19	18	4	46.34%	否
52.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，胃扩张、胃形态正常，可考虑行管裂孔疝修补+Re-SG+胃底折叠术	18	18	5	43.90%	否
53.减重效果不理想/复胖，GERD诊断明确又无明确HH的患者，胃扩张、胃形态正常，可考虑行Re-SG+His角重建	24	15	2	54.54%	否
54.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，胃扩张、胃形态正常，可考虑行管裂孔疝修补+Re-SG+His角重建	21	18	2	51.22%	否
55.减重效果不理想/复胖，GERD诊断明确又没有明确HH的患者，无胃扩张/胃扭转，可考虑行RYGB	35	5	1	85.37%	是
56.减重效果不理想/复胖，GERD诊断明确又有明确HH的患者，无胃扩张/胃扭转，可考虑行HH修补+RYGB	39	1	1	95.12%	是
57.减重效果理想，残胃狭窄引起的GERD，反复内镜下扩张失败的，可考虑行RYGB	37	3	1	90.24%	是
58.减重效果不理想/复胖，残胃狭窄引起的GERD，可考虑行RYGB	39	2	0	95.12%	是
59.若修正手术前合并难以纠正的贫血/营养不良，应慎重考虑RYGB	38	3	0	92.68%	是

[1]	世界肥胖联盟, 2024世界肥胖报告 [EB/OL]. 伦敦: 世界肥胖联盟, 2024. URL
[2]	Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials [J]. BMJ, 2013, 347: f5934.
[3]	Howard R, Chao GF, Yang J, et al. Comparative Safety of sleeve gastrectomy and gastric bypass up to 5 years after surgery in patients with severe obesity [J]. JAMA Surg, 2021, 156(12): 1160-1169.
[4]	中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2023年度报告 [J/CD]. 中华肥胖与代谢病电子杂志, 2024, 10(2): 73-83.
[5]	Johnston D, Dachtler J, Sue-Ling HM, et al. The Magenstrasse and Mill operation for morbid obesity [J]. Obes Surg, 2003, 13(1): 10-16.
[6]	ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure [J]. Surg Obes Relat Dis, 2012, 8(3): e21-26.
[7]	Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity [J]. Annals of surgery, 2010, 252(2): 319-324.
[8]	Keren D, Matter I, Rainis T, et al. Getting the most from the sleeve: the importance of post-operative follow-up [J]. Obes Surg, 2011, 21(12): 1887-1893.
[9]	Ali M, El Chaar M, Ghiassi S, et al. American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure [J]. Surg Obes Relat Dis, 2017, 13(10): 1652-1657.
[10]	Pill J. The Delphi method: Substance, context, a critique and an annotated bibliography [J]. Socio-Economic Planning Sciences, 1971, 5(1): 57-71.
[11]	Eusebi L H, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis [J]. Gut, 2018, 67(3): 430-440.
[12]	Lagergren J. Influence of obesity on the risk of esophageal disorders [J]. Nat Rev Gastroenterol Hepatol, 2011, 8(6): 340-347.
[13]	Yadlapati R, Gyawali CP, Pandolfino JE. AGA Clinical Practice Update on the personalized approach to the evaluation and management of GERD: expert review [J]. Clin Gastroenterol Hepatol, 2022, 20(5): 984-994.e981.
[14]	Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss [J]. JAMA Surg, 2016, 151(11): 1046-1055.
[15]	Aili A, Maimaitiming M, Maimaitiyusufu P, et al. Gastroesophageal reflux related changes after sleeve gastrectomy and sleeve gastrectomy with fundoplication: A retrospective single center study [J]. Front Endocrinol (Lausanne), 2022, 13: 1041889.
[16]	Clapp B, Wynn M, Martyn C, et al. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis [J]. Surg Obes Relat Dis, 2018, 14(6): 741-747.
[17]	Oor JE, Roks DJ, ünlü Ç, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis [J]. Am J Surg, 2016, 211(1): 250-267.
[18]	Laffin M, Chau J, Gill RS, et al. Sleeve gastrectomy and gastroesophageal reflux disease [J]. J Obes, 2013, 2013: 741097.
[19]	高尚, 刘金钢. 袖状胃切除术的精准应用 [J]. 中华胃肠外科杂志, 2022, 25(10): 881-885.
[20]	Assalia A, Gagner M, Nedelcu M, et al. Gastroesophageal reflux and laparoscopic sleeve gastrectomy: results of the first international consensus conference [J]. Obes Surg, 2020, 30(10): 3695-3705.
[21]	DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis [J]. JAMA Surg, 2014, 149(4): 328-334.
[22]	Borbély Y, Kröll D, Nett PC, et al. Radiologic, endoscopic, and functional patterns in patients with symptomatic gastroesophageal reflux disease after Roux-en-Y gastric bypass [J]. Surg Obes Relat Dis, 2018, 14(6): 764-768.
[23]	中华医学会消化病学分会胃肠动力学组, 胃肠功能性疾病协作组, 食管疾病协作组. 中国胃食管反流病诊疗规范 [J]. 中华消化杂志, 2023, 43(9): 588-598.
[24]	Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease [J]. Gastroenterology, 2018, 154(2): 267-276.
[25]	Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study [J]. E Clinical Medicine, 2022, 47: 101404.
[26]	Morgan E, Soerjomataram I, Rumgay H, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020 [J]. Gastroenterology, 2022, 163(3): 649-658. e642.
[27]	Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the diagnosis and management of gastroesophageal reflux disease [J]. Am J Gastroenterol, 2022, 117(1): 27-56.
[28]	Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus: An updated ACG Guideline [J]. Am J Gastroenterol, 2022, 117(4): 559-587.
[29]	Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis [J]. Am J Gastroenterol, 1999, 94(10): 2840-2844.
[30]	Castagneto-Gissey L, Russo MF, D'Andrea V, et al. Efficacy of sleeve gastrectomy with concomitant hiatal hernia repair versus sleeve-fundoplication on gastroesophageal reflux disease resolution: systematic review and meta-analysis [J]. J Clin Med, 2023, 12(9).
[31]	Soricelli E, Iossa A, Casella G, et al. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia [J]. Surg Obes Relat Dis, 2013, 9(3): 356-361.
[32]	Suter M, Dorta G, Giusti V, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients [J]. Obes Surg, 2004, 14(7): 959-966.
[33]	Schneider JH, Küper M, Königsrainer A, et al. Transient lower esophageal sphincter relaxation in morbid obesity [J]. Obes Surg, 2009, 19(5): 595-600.
[34]	de Mello Del Grande L, Herbella FAM, Katayama RC, et al. Transdiaphragmatic pressure gradient (TPG) Has a central role in the pathophysiology of gastroesophageal reflux disease (GERD) in the obese and it correlates with abdominal circumference but not with body mass index (BMI) [J]. Obes Surg, 2020, 30(4): 1424-1428.
[35]	Jung HK, Tae CH, Song KH, et al. 2020 Seoul Consensus on the diagnosis and management of gastroesophageal reflux disease [J]. J Neurogastroenterol Motil, 2021, 27(4): 453-481.
[36]	Iwakiri K, Fujiwara Y, Manabe N, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021 [J]. J Gastroenterol, 2022, 57(4): 267-285.
[37]	Santonicola A, Angrisani L, Vitiello A, et al. Hiatal hernia diagnosis prospectively assessed in obese patients before bariatric surgery: accuracy of high-resolution manometry taking intraoperative diagnosis as reference standard [J]. Surg Endosc, 2020, 34(3): 1150-1156.
[38]	Brajcich BC, Hungness ES. Sleeve gastrectomy [J]. JAMA, 2020, 324(9): 908.
[39]	Popescu AL, Ioniţa-Radu F, Jinga M, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux [J]. Rom J Intern Med, 2018, 56(4): 227-232.
[40]	Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease [J]. JAMA, 2020, 324(24): 2565.
[41]	Trujillo AB, Sagar D, Amaravadhi AR, et al. Incidence of post-operative gastro-esophageal reflux disorder in patients undergoing laparoscopic sleeve gastrectomy: a systematic review and meta-analysis [J]. Obes Surg, 2024, 34(5): 1874-1884.
[42]	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 腹腔镜袖状胃切除术操作指南(2018版) [J/CD]. 中华肥胖与代谢病电子杂志, 2018, (4): 196-201
[43]	Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux? A systematic review and meta-analysis [J]. Annals of surgery, 2020, 271(2): 257-265.
[44]	McGlone ER, Gupta AK, Reddy M, et al. Antral resection versus antral preservation during laparoscopic sleeve gastrectomy for severe obesity: Systematic review and meta-analysis [J]. Surg Obes Relat Dis, 2018, 14(6): 857-864.
[45]	Eskandaros MS. Antrum preservation versus antrum resection in laparoscopic sleeve gastrectomy with effects on gastric emptying, body mass index, and type ii diabetes remission in diabetic patients with body mass index 30-40 kg/m²: a randomized controlled study [J]. Obes Surg, 2022, 32(5): 1412-1420.
[46]	Pizza F, D'Antonio D, Lucido FS, et al. Does antrum size matter in sleeve gastrectomy? A prospective randomized study [J]. Surg Endosc, 2021, 35(7): 3524-3532.
[47]	Wang Y, Yi XY, Gong LL, et al. The effectiveness and safety of laparoscopic sleeve gastrectomy with different sizes of bougie calibration: A systematic review and meta-analysis [J]. Int J Surg, 2018, 49: 32-38.
[48]	Chang PC, Chen KH, Jhou HJ, et al. Promising effects of 33 to 36 Fr. bougie calibration for laparoscopic sleeve gastrectomy: a systematic review and network meta-analysis [J]. Sci Rep, 2021, 11(1): 15217.
[49]	Rosenthal RJ, Diaz AA, Arvidsson D, et al. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases [J]. Surg Obes Relat Dis, 2012, 8(1): 8-19.
[50]	Lazoura O, Zacharoulis D, Triantafyllidis G, et al. Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology [J]. Obes Surg, 2011, 21(3): 295-299.
[51]	Daes J, Jimenez ME, Said N, et al. Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique [J]. Obes Surg, 2012, 22(12): 1874-1879.
[52]	Yu HX, Han CS, Xue JR, et al. Esophageal hiatal hernia: risk, diagnosis and management [J]. Expert Rev Gastroenterol Hepatol, 2018, 12(4): 319-329.
[53]	Kohn GP, Price RR, DeMeester SR, et al. Guidelines for the management of hiatal hernia [J]. Surg Endosc, 2013, 27(12): 4409-4428.
[54]	Olmi S, Cesana G, Gambioli A, et al. Correction to: effect of laparoscopic sleeve gastrectomy vs laparoscopic sleeve + rossetti fundoplication on weight loss and De Novo GERD in patients affected by morbid obesity: a randomized clinical study [J]. Obes Surg, 2022, 32(6): 2102.
[55]	Talha A, Ibrahim M. Laparoscopic Nissen Fundoplication Plus mid-gastric plication for treatment of obese patients with gastroesophageal reflux disease [J]. Obes Surg, 2018, 28(2): 437-443.
[56]	Olmi S, Caruso F, Uccelli M, et al. Laparoscopic sleeve gastrectomy combined with Rossetti fundoplication (R-Sleeve) for treatment of morbid obesity and gastroesophageal reflux [J]. Surg Obes Relat Dis, 2017, 13(12): 1945-1950.
[57]	花荣, 姚琪远, 丁锐, 等. 腹腔镜胃底联合大弯侧折叠治疗肥胖症伴胃食管反流疗效分析 [J]. 中国实用外科杂志, 2014, 34(11): 1068-1071.
[58]	花荣, 陈浩, 丁锐, 等. 袖状胃切除手术前后的胃食管反流病 [J]. 外科理论与实践, 2017, 22(6): 493-498.
[59]	Wu WY, Chang SC, Hsu JT, et al. Gastroesophageal reflux disease symptoms after laparoscopic sleeve gastrectomy: a retrospective study [J]. J Pers Med, 2022, 12(11).
[60]	Znamirowski P, Kołomańska M, Mazurkiewicz R, et al. GERD as a complication of laparoscopic sleeve gastrectomy for the treatment of obesity: a systematic review and meta-analysis [J]. J Pers Med, 2023, 13(8).
[61]	Salminen P, Grönroos S, Helmiö M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial [J]. JAMA Surg, 2022, 157(8): 656-666.
[62]	Fisher OM, Chan DL, Talbot M L, et al. Barrett's oesophagus and bariatric/metabolic surgery-IFSO 2020 position statement [J]. Obes Surg, 2021, 31(3): 915-934.
[63]	Nadaleto BF, Herbella FA, Patti MG. Gastroesophageal reflux disease in the obese: Pathophysiology and treatment [J]. Surgery, 2016, 159(2): 475-486.
[64]	Braghetto I, Lanzarini E, Korn O, et al. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients [J]. Obes Surg, 2010, 20(3): 357-362.
[65]	Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus [J]. Gut, 2018, 67(7): 1351-1362.
[66]	Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0 [J]. GUT, 2024, 73(2): 361-371.
[67]	王志, 张成, 王俭, 等. GerdQ量表在胃食管反流病诊断中的应用 [J]. 中华胃食管反流病电子杂志, 2014, 1(01): 36-38
[68]	Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study [J]. GUT, 2010, 59(6): 714-721.
[69]	Campos GM, Mazzini GS, Altieri MS, et al. ASMBS position statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery [J]. Surg Obes Relat Dis, 2021, 17(5): 837-847.
[70]	中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组. 中国肥胖及代谢疾病外科治疗指南(2024版) [J]. 中国实用外科杂志, 2024, 44(08): 841-849.
[71]	Tai CM, Huang CK, Lee YC, et al. Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults [J]. Surg Endosc, 2013, 27(4): 1260-1266.
[72]	Treitl D, Nieber D, Ben-David K. Operative treatments for reflux after bariatric surgery: current and emerging management options [J]. J Gastrointest Surg, 2017, 21(3): 577-582.
[73]	King K, Sudan R, Bardaro S, et al. Assessment and management of gastroesophageal reflux disease following bariatric surgery [J]. Surg Obes Relat Dis, 2021, 17(11): 1919-1925.
[74]	Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders [J]. Gastroenterology, 2016.
[75]	Dickman R, Maradey-Romero C, Fass R. The role of pain modulators in esophageal disorders - no pain no gain [J]. Neurogastroenterol Motil, 2014, 26(5): 603-610.
[76]	Riehl ME, Chen JW. The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness [J]. Curr Gastroenterol Rep, 2018, 20(7): 34.
[77]	Halland M, Bharucha AE, Crowell MD, et al. Effects of diaphragmatic breathing on the pathophysiology and treatment of upright gastroesophageal reflux: a randomized controlled trial [J]. Am J Gastroenterol, 2021, 116(1): 86-94.
[78]	Sawada A, Anastasi N, Green A, et al. Management of supragastric belching with cognitive behavioural therapy: factors determining success and follow-up outcomes at 6-12 months post-therapy [J]. Aliment Pharmacol Ther, 2019, 50(5): 530-537.
[79]	Khidir N, Angrisani L, Al-Qahtani J, et al. Initial experience of endoscopic radiofrequency waves delivery to the lower esophageal sphincter (stretta procedure) on symptomatic gastroesophageal reflux disease post-sleeve gastrectomy [J]. Obes Surg, 2018, 28(10): 3125-3130.
[80]	Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later [J]. Surg Endosc, 2014, 28(8): 2323-2333.
[81]	Borbély Y, Bouvy N, Schulz H G, et al. Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy [J]. Surg Obes Relat Dis, 2018, 14(5): 611-615.
[82]	Chiappetta S, Lainas P, Kassir R, et al. Gastroesophageal reflux disease as an indication of revisional bariatric surgery-indication and results-a systematic review and metanalysis [J]. Obes Surg, 2022, 32(9): 3156-3171.
[83]	MacVicar S, Mocanu V, Jogiat U, et al. Revisional bariatric surgery for gastroesophageal reflux disease: characterizing patient and procedural factors and 30-day outcomes for a retrospective cohort of 4412 patients [J]. Surg Endosc, 2024, 38(1): 75-84.
[84]	Yorke E, Sheppard C, Switzer NJ, et al. Revision of sleeve gastrectomy to Roux-en-Y Gastric bypass: a Canadian experience [J]. Am J Surg, 2017, 213(5): 970-974.
[85]	Landreneau JP, Strong AT, Rodriguez JH, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass [J]. Obes Surg, 2018, 28(12): 3843-3850.
[86]	Parmar CD, Mahawar KK, Boyle M, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss [J]. Obes Surg, 2017, 27(7): 1651-1658.
[87]	梁辉. 腹腔镜袖状胃切除术后再手术策略 [J]. 中华消化外科杂志, 2022, 21(11): 1415-1421.
[88]	Matar R, Monzer N, Jaruvongvanich V, et al. Indications and outcomes of conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: a systematic review and a meta-analysis [J]. Obes Surg, 2021, 31(9): 3936-3946.
[89]	Azagury D, Morton J. Surgical anti-reflux options beyond fundoplication [J]. Curr Gastroenterol Rep, 2017, 19(7): 35.
[90]	Bona D, Zappa MA, Panizzo V, et al. Laparoscopic management of pathologic gastroesophageal reflux after sleeve gastrectomy using the magnetic sphincter augmentation (MSA) device-a Video Vignette [J]. Obes Surg, 2022, 32(5): 1791-1793.
[91]	Desart K, Rossidis G, Michel M, et al. Gastroesophageal reflux management with the LINX® System for gastroesophageal reflux disease following laparoscopic sleeve gastrectomy [J]. J Gastrointest Surg, 2015, 19(10): 1782-1786.
[92]	Hawasli A, Sadoun M, Meguid A, et al. Laparoscopic placement of the LINX(®) system in management of severe reflux after sleeve gastrectomy [J]. Am J Surg, 2019, 217(3): 496-499.
[93]	Broderick RC, Smith CD, Cheverie JN, et al. Magnetic sphincter augmentation: a viable rescue therapy for symptomatic reflux following bariatric surgery [J]. Surg Endosc, 2020, 34(7): 3211-3215.
[94]	Khaitan L, Hill M, Michel M, et al. Feasibility and efficacy of magnetic sphincter augmentation for the management of gastroesophageal reflux disease post-sleeve gastrectomy for obesity [J]. Obes Surg, 2023, 33(1): 387-396.
[95]	Smith CD, Ganz RA, Lipham JC, et al. Lower Esophageal sphincter augmentation for gastroesophageal reflux disease: the safety of a modern implant [J]. J Laparoendosc Adv Surg Tech A, 2017, 27(6): 586-591.
[96]	Ndubizu GU, Petrick AT, Horsley R. Concurrent magnetic sphincter augmentation and hiatal hernia repair for refractory GERD after laparoscopic sleeve gastrectomy [J]. Surg Obes Relat Dis, 2020, 16(1): 168-170.
[97]	Hider AM, Bonham AJ, Carlin AM, et al. Impact of concurrent hiatal hernia repair during laparoscopic sleeve gastrectomy on patient-reported gastroesophageal reflux symptoms: a state-wide analysis [J]. Surg Obes Relat Dis, 2023, 19(6): 619-625.
[98]	Chen W, Feng J, Wang C, et al. Effect of concomitant laparoscopic sleeve gastrectomy and hiatal hernia repair on gastroesophageal reflux disease in patients with obesity: a systematic review and meta-analysis [J]. Obes Surg, 2021, 31(9): 3905-3918.
[99]	Macedo FIB, Mowzoon M, Mittal VK, et al. Outcomes of laparoscopic hiatal hernia repair in nine bariatric patients with prior sleeve gastrectomy [J]. Obes Surg, 2017, 27(10): 2768-2772.
[100]	Vaughan T, Romero-Velez G, Barajas-Gamboa JS, et al. Hiatal hernia repair after previous laparoscopic Roux-en-Y gastric bypass [J]. Surg Obes Relat Dis, 2024, 20(5): 432-437.
[101]	Indja B, Chan DL, Talbot ML. Hiatal reconstruction is safe and effective for control of reflux after laparoscopic sleeve gastrectomy [J]. BMC Surg, 2022, 22(1): 347.
[102]	Baumann T, Grueneberger J, Pache G, et al. Three-dimensional stomach analysis with computed tomography after laparoscopic sleeve gastrectomy: sleeve dilation and thoracic migration [J]. Surg Endosc, 2011, 25(7): 2323-2329.
[103]	Hill L D. An effective operation for hiatal hernia: an eight year appraisal [J]. Annals of surgery, 1967, 166(4): 681-692.
[104]	Abou-Ashour HS. Impact of gastropexy/omentopexy on gastrointestinal symptoms after laparoscopic sleeve gastrectomy [J]. Obes Surg, 2022, 32(3): 729-736.
[105]	Afaneh C, Costa R, Pomp A, et al. A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms [J]. Surg Endosc, 2015, 29(1): 41-47.
[106]	Flølo TN, Fosså A, Nedkvitne JIP, et al. Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy [J]. Clin Obes, 2023, 13(5): e12618.
[107]	Soong T C, Almalki O M, Lee W J, et al. Revision of sleeve gastrectomy with hiatal repair with gastropexy for gastroesophageal reflux disease [J]. Obes Surg, 2019, 29(8): 2381-2386.
[108]	Aiolfi A, Micheletto G, Marin J, et al. Resleeve for failed laparoscopic sleeve gastrectomy: systematic review and meta-analysis [J]. Surg Obes Relat Dis, 2020, 16(10): 1383-1391.
[109]	Mehmet B. Re-sleeve gastrectomy for failed primary laparoscopic sleeve gastrectomy [J]. J Coll Physicians Surg Pak, 2019, 29(1): 62-65.
[110]	Franken RJ, Sluiter NR, Franken J, et al. Treatment options for weight regain or insufficient weight loss after sleeve gastrectomy: a systematic review and meta-analysis [J]. Obes Surg, 2022, 32(6): 2035-2046.
[111]	Loo JH, Chue KM, Lim CH, et al. Effectiveness of sleeve gastrectomy plus fundoplication versus sleeve gastrectomy alone for treatment of patients with severe obesity: a systematic review and meta-analysis [J]. Surg Obes Relat Dis, 2024, 20(6): 532-543.
[112]	Mu S Z, Saber A A. Gastroesophageal reflux disease and weight loss after fundoplication sleeve gastrectomy: a systematic review and meta-analysis [J]. Obes Surg, 2024, 34(2): 318-329.
[113]	Dang JT, Vaughan T, Mocanu V, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications, prevalence, and safety [J]. Obes Surg, 2023, 33(5): 1486-1493.
[114]	Strauss AL, Triggs JR, Tewksbury CM, et al. Conversion to Roux-En-Y Gastric Bypass: a successful means of mitigating reflux after laparoscopic sleeve gastrectomy [J]. Surg Endosc, 2023, 37(7): 5374-5379.
[115]	Friedman A, Li YH, Seip RL, et al. Incidence of hiatal hernia repair during primary bariatric surgery conversion: an analysis of the 2020 MBSAQIP Database [J]. Obes Surg, 2023, 33(5): 1613-1615.
[116]	Felinska E, Billeter A, Nickel F, et al. Do we understand the pathophysiology of GERD after sleeve gastrectomy? [J]. Ann N Y Acad Sci, 2020, 1482(1): 26-35.
[117]	Mazer L, Yu JX, Bhalla S, et al. Pneumatic Balloon Dilation of Gastric Sleeve Stenosis Is Not Associated with Weight Regain [J]. Obes Surg, 2022, 32(7): 1-6.
[118]	Chang SH, Popov VB, Thompson CC. Endoscopic balloon dilation for treatment of sleeve gastrectomy stenosis: a systematic review and meta-analysis [J]. Gastrointest Endosc, 2020, 91(5): 989-1002. e1004.
[119]	Gasmi A, Bjørklund G, Mujawdiya PK, et al. Micronutrients deficiences in patients after bariatric surgery [J]. Eur J Nutr, 2022, 61(1): 55-67.
[120]	McCracken E, Wood GC, Prichard W, et al. Severe anemia after Roux-en-Y gastric bypass: a cause for concern [J]. Surg Obes Relat Dis, 2018, 14(7): 902-909.

[1]	曾敬, 吴冬冬, 邵明, 范震波, 王治国, 刘培谊, 兰海峰. 高龄髋部骨折患者不同手术时机的围手术期疗效评估[J]. 中华关节外科杂志(电子版), 2024, 18(04): 445-449.
[2]	吕小飞, 赵舸. 皮下预置盲襻型胆肠吻合术治疗成人先天性胆管扩张症[J]. 中华普通外科学文献(电子版), 2024, 18(04): 258-261.
[3]	康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[4]	付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[5]	孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[6]	许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[7]	张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[8]	曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[9]	向辉, 贾晓斌, 全卫涛. 真空辅助乳腺微创旋切术治疗乳腺纤维瘤的效果及并发症观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 528-530.
[10]	王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[11]	李澄清, 郭文毅, 王磊. 腹腔镜保留脾脏胰体尾切除术：微创胰腺外科的合理决策[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 620-624.
[12]	罗柳平, 吴萌萌, 陈欣磊, 林科灿. 胰腺全系膜切除在胰头癌根治术中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 651-656.
[13]	韩青雷, 丛赟, 李佳隆, 邵英梅. 术前减黄方式对壶腹周围癌胰十二指肠切除术后并发症的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 665-669.
[14]	唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[15]	王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Experts consensus on the diagnosis and treatment of gastroesophageal reflux disease in patients undergoing sleeve gastrectomy (2024 Edition)

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Experts consensus on the diagnosis and treatment of gastroesophageal reflux disease in patients undergoing sleeve gastrectomy (2024 Edition)